img

Global T Cell Surface Glycoprotein CD4 Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global T Cell Surface Glycoprotein CD4 Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

T Cell Surface Glycoprotein CD4 report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global T Cell Surface Glycoprotein CD4 market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from HIV and AIDS are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for T Cell Surface Glycoprotein CD4 industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, T Cell Surface Glycoprotein CD4 key manufacturers include Biotest AG, Bristol-Myers Squibb Co, CEL-SCI Corp, Fountain Biopharma Inc, Immupharma Plc, Sanofi, TaiMed Biologics Inc and United Biomedical Inc, etc. Biotest AG, Bristol-Myers Squibb Co, CEL-SCI Corp are top 3 players and held % sales share in total in 2022.
T Cell Surface Glycoprotein CD4 can be divided into Forigerimod Acetate, HIV Vaccine 2, Ibalizumab and Others, etc. Forigerimod Acetate is the mainstream product in the market, accounting for % sales share globally in 2022.
T Cell Surface Glycoprotein CD4 is widely used in various fields, such as HIV, AIDS, GVHD and SARS, etc. HIV provides greatest supports to the T Cell Surface Glycoprotein CD4 industry development. In 2022, global % sales of T Cell Surface Glycoprotein CD4 went into HIV filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global T Cell Surface Glycoprotein CD4 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Biotest AG
Bristol-Myers Squibb Co
CEL-SCI Corp
Fountain Biopharma Inc
Immupharma Plc
Sanofi
TaiMed Biologics Inc
United Biomedical Inc
Segment by Type
Forigerimod Acetate
HIV Vaccine 2
Ibalizumab
Others

Segment by Application


HIV
AIDS
GVHD
SARS
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the T Cell Surface Glycoprotein CD4 market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of T Cell Surface Glycoprotein CD4, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the T Cell Surface Glycoprotein CD4 industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of T Cell Surface Glycoprotein CD4 in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, T Cell Surface Glycoprotein CD4 introduction, etc. T Cell Surface Glycoprotein CD4 Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of T Cell Surface Glycoprotein CD4 market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 T Cell Surface Glycoprotein CD4 Market Overview
1.1 T Cell Surface Glycoprotein CD4 Product Overview
1.2 T Cell Surface Glycoprotein CD4 Market Segment by Type
1.2.1 Forigerimod Acetate
1.2.2 HIV Vaccine 2
1.2.3 Ibalizumab
1.2.4 Others
1.3 Global T Cell Surface Glycoprotein CD4 Market Size by Type
1.3.1 Global T Cell Surface Glycoprotein CD4 Market Size Overview by Type (2018-2034)
1.3.2 Global T Cell Surface Glycoprotein CD4 Historic Market Size Review by Type (2018-2024)
1.3.3 Global T Cell Surface Glycoprotein CD4 Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America T Cell Surface Glycoprotein CD4 Sales Breakdown by Type (2018-2024)
1.4.2 Europe T Cell Surface Glycoprotein CD4 Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific T Cell Surface Glycoprotein CD4 Sales Breakdown by Type (2018-2024)
1.4.4 Latin America T Cell Surface Glycoprotein CD4 Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa T Cell Surface Glycoprotein CD4 Sales Breakdown by Type (2018-2024)
2 Global T Cell Surface Glycoprotein CD4 Market Competition by Company
2.1 Global Top Players by T Cell Surface Glycoprotein CD4 Sales (2018-2024)
2.2 Global Top Players by T Cell Surface Glycoprotein CD4 Revenue (2018-2024)
2.3 Global Top Players by T Cell Surface Glycoprotein CD4 Price (2018-2024)
2.4 Global Top Manufacturers T Cell Surface Glycoprotein CD4 Manufacturing Base Distribution, Sales Area, Product Type
2.5 T Cell Surface Glycoprotein CD4 Market Competitive Situation and Trends
2.5.1 T Cell Surface Glycoprotein CD4 Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by T Cell Surface Glycoprotein CD4 Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in T Cell Surface Glycoprotein CD4 as of 2022)
2.7 Date of Key Manufacturers Enter into T Cell Surface Glycoprotein CD4 Market
2.8 Key Manufacturers T Cell Surface Glycoprotein CD4 Product Offered
2.9 Mergers & Acquisitions, Expansion
3 T Cell Surface Glycoprotein CD4 Status and Outlook by Region
3.1 Global T Cell Surface Glycoprotein CD4 Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global T Cell Surface Glycoprotein CD4 Historic Market Size by Region
3.2.1 Global T Cell Surface Glycoprotein CD4 Sales in Volume by Region (2018-2024)
3.2.2 Global T Cell Surface Glycoprotein CD4 Sales in Value by Region (2018-2024)
3.2.3 Global T Cell Surface Glycoprotein CD4 Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global T Cell Surface Glycoprotein CD4 Forecasted Market Size by Region
3.3.1 Global T Cell Surface Glycoprotein CD4 Sales in Volume by Region (2024-2034)
3.3.2 Global T Cell Surface Glycoprotein CD4 Sales in Value by Region (2024-2034)
3.3.3 Global T Cell Surface Glycoprotein CD4 Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global T Cell Surface Glycoprotein CD4 by Application
4.1 T Cell Surface Glycoprotein CD4 Market Segment by Application
4.1.1 HIV
4.1.2 AIDS
4.1.3 GVHD
4.1.4 SARS
4.1.5 Others
4.2 Global T Cell Surface Glycoprotein CD4 Market Size by Application
4.2.1 Global T Cell Surface Glycoprotein CD4 Market Size Overview by Application (2018-2034)
4.2.2 Global T Cell Surface Glycoprotein CD4 Historic Market Size Review by Application (2018-2024)
4.2.3 Global T Cell Surface Glycoprotein CD4 Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America T Cell Surface Glycoprotein CD4 Sales Breakdown by Application (2018-2024)
4.3.2 Europe T Cell Surface Glycoprotein CD4 Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific T Cell Surface Glycoprotein CD4 Sales Breakdown by Application (2018-2024)
4.3.4 Latin America T Cell Surface Glycoprotein CD4 Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa T Cell Surface Glycoprotein CD4 Sales Breakdown by Application (2018-2024)
5 North America T Cell Surface Glycoprotein CD4 by Country
5.1 North America T Cell Surface Glycoprotein CD4 Historic Market Size by Country
5.1.1 North America T Cell Surface Glycoprotein CD4 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America T Cell Surface Glycoprotein CD4 Sales in Volume by Country (2018-2024)
5.1.3 North America T Cell Surface Glycoprotein CD4 Sales in Value by Country (2018-2024)
5.2 North America T Cell Surface Glycoprotein CD4 Forecasted Market Size by Country
5.2.1 North America T Cell Surface Glycoprotein CD4 Sales in Volume by Country (2024-2034)
5.2.2 North America T Cell Surface Glycoprotein CD4 Sales in Value by Country (2024-2034)
6 Europe T Cell Surface Glycoprotein CD4 by Country
6.1 Europe T Cell Surface Glycoprotein CD4 Historic Market Size by Country
6.1.1 Europe T Cell Surface Glycoprotein CD4 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe T Cell Surface Glycoprotein CD4 Sales in Volume by Country (2018-2024)
6.1.3 Europe T Cell Surface Glycoprotein CD4 Sales in Value by Country (2018-2024)
6.2 Europe T Cell Surface Glycoprotein CD4 Forecasted Market Size by Country
6.2.1 Europe T Cell Surface Glycoprotein CD4 Sales in Volume by Country (2024-2034)
6.2.2 Europe T Cell Surface Glycoprotein CD4 Sales in Value by Country (2024-2034)
7 Asia-Pacific T Cell Surface Glycoprotein CD4 by Region
7.1 Asia-Pacific T Cell Surface Glycoprotein CD4 Historic Market Size by Region
7.1.1 Asia-Pacific T Cell Surface Glycoprotein CD4 Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific T Cell Surface Glycoprotein CD4 Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific T Cell Surface Glycoprotein CD4 Sales in Value by Region (2018-2024)
7.2 Asia-Pacific T Cell Surface Glycoprotein CD4 Forecasted Market Size by Region
7.2.1 Asia-Pacific T Cell Surface Glycoprotein CD4 Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific T Cell Surface Glycoprotein CD4 Sales in Value by Region (2024-2034)
8 Latin America T Cell Surface Glycoprotein CD4 by Country
8.1 Latin America T Cell Surface Glycoprotein CD4 Historic Market Size by Country
8.1.1 Latin America T Cell Surface Glycoprotein CD4 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America T Cell Surface Glycoprotein CD4 Sales in Volume by Country (2018-2024)
8.1.3 Latin America T Cell Surface Glycoprotein CD4 Sales in Value by Country (2018-2024)
8.2 Latin America T Cell Surface Glycoprotein CD4 Forecasted Market Size by Country
8.2.1 Latin America T Cell Surface Glycoprotein CD4 Sales in Volume by Country (2024-2034)
8.2.2 Latin America T Cell Surface Glycoprotein CD4 Sales in Value by Country (2024-2034)
9 Middle East and Africa T Cell Surface Glycoprotein CD4 by Country
9.1 Middle East and Africa T Cell Surface Glycoprotein CD4 Historic Market Size by Country
9.1.1 Middle East and Africa T Cell Surface Glycoprotein CD4 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa T Cell Surface Glycoprotein CD4 Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa T Cell Surface Glycoprotein CD4 Sales in Value by Country (2018-2024)
9.2 Middle East and Africa T Cell Surface Glycoprotein CD4 Forecasted Market Size by Country
9.2.1 Middle East and Africa T Cell Surface Glycoprotein CD4 Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa T Cell Surface Glycoprotein CD4 Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Biotest AG
10.1.1 Biotest AG Company Information
10.1.2 Biotest AG Introduction and Business Overview
10.1.3 Biotest AG T Cell Surface Glycoprotein CD4 Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Biotest AG T Cell Surface Glycoprotein CD4 Products Offered
10.1.5 Biotest AG Recent Development
10.2 Bristol-Myers Squibb Co
10.2.1 Bristol-Myers Squibb Co Company Information
10.2.2 Bristol-Myers Squibb Co Introduction and Business Overview
10.2.3 Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Products Offered
10.2.5 Bristol-Myers Squibb Co Recent Development
10.3 CEL-SCI Corp
10.3.1 CEL-SCI Corp Company Information
10.3.2 CEL-SCI Corp Introduction and Business Overview
10.3.3 CEL-SCI Corp T Cell Surface Glycoprotein CD4 Sales, Revenue and Gross Margin (2018-2024)
10.3.4 CEL-SCI Corp T Cell Surface Glycoprotein CD4 Products Offered
10.3.5 CEL-SCI Corp Recent Development
10.4 Fountain Biopharma Inc
10.4.1 Fountain Biopharma Inc Company Information
10.4.2 Fountain Biopharma Inc Introduction and Business Overview
10.4.3 Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Products Offered
10.4.5 Fountain Biopharma Inc Recent Development
10.5 Immupharma Plc
10.5.1 Immupharma Plc Company Information
10.5.2 Immupharma Plc Introduction and Business Overview
10.5.3 Immupharma Plc T Cell Surface Glycoprotein CD4 Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Immupharma Plc T Cell Surface Glycoprotein CD4 Products Offered
10.5.5 Immupharma Plc Recent Development
10.6 Sanofi
10.6.1 Sanofi Company Information
10.6.2 Sanofi Introduction and Business Overview
10.6.3 Sanofi T Cell Surface Glycoprotein CD4 Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Sanofi T Cell Surface Glycoprotein CD4 Products Offered
10.6.5 Sanofi Recent Development
10.7 TaiMed Biologics Inc
10.7.1 TaiMed Biologics Inc Company Information
10.7.2 TaiMed Biologics Inc Introduction and Business Overview
10.7.3 TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Sales, Revenue and Gross Margin (2018-2024)
10.7.4 TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Products Offered
10.7.5 TaiMed Biologics Inc Recent Development
10.8 United Biomedical Inc
10.8.1 United Biomedical Inc Company Information
10.8.2 United Biomedical Inc Introduction and Business Overview
10.8.3 United Biomedical Inc T Cell Surface Glycoprotein CD4 Sales, Revenue and Gross Margin (2018-2024)
10.8.4 United Biomedical Inc T Cell Surface Glycoprotein CD4 Products Offered
10.8.5 United Biomedical Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 T Cell Surface Glycoprotein CD4 Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 T Cell Surface Glycoprotein CD4 Industrial Chain Analysis
11.4 T Cell Surface Glycoprotein CD4 Market Dynamics
11.4.1 T Cell Surface Glycoprotein CD4 Industry Trends
11.4.2 T Cell Surface Glycoprotein CD4 Market Drivers
11.4.3 T Cell Surface Glycoprotein CD4 Market Challenges
11.4.4 T Cell Surface Glycoprotein CD4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 T Cell Surface Glycoprotein CD4 Distributors
12.3 T Cell Surface Glycoprotein CD4 Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Forigerimod Acetate
Table 2. Major Company of HIV Vaccine 2
Table 3. Major Company of Ibalizumab
Table 4. Major Company of Others
Table 5. Global T Cell Surface Glycoprotein CD4 Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global T Cell Surface Glycoprotein CD4 Sales by Type (2018-2024) & (K Pcs)
Table 7. Global T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Type (2018-2024)
Table 8. Global T Cell Surface Glycoprotein CD4 Sales by Type (2018-2024) & (US& Million)
Table 9. Global T Cell Surface Glycoprotein CD4 Market Share in Value by Type (2018-2024)
Table 10. Global T Cell Surface Glycoprotein CD4 Price by Type (2018-2024) & (USD/Pcs)
Table 11. Global T Cell Surface Glycoprotein CD4 Sales by Type (2024-2034) & (K Pcs)
Table 12. Global T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Type (2024-2034)
Table 13. Global T Cell Surface Glycoprotein CD4 Sales by Type (2024-2034) & (US$ Million)
Table 14. Global T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Type (2024-2034)
Table 15. Global T Cell Surface Glycoprotein CD4 Price by Type (2024-2034) & (USD/Pcs)
Table 16. North America T Cell Surface Glycoprotein CD4 Sales by Type (2018-2024) & (K Pcs)
Table 17. North America T Cell Surface Glycoprotein CD4 Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe T Cell Surface Glycoprotein CD4 Sales (K Pcs) by Type (2018-2024)
Table 19. Europe T Cell Surface Glycoprotein CD4 Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales (K Pcs) by Type (2018-2024)
Table 21. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America T Cell Surface Glycoprotein CD4 Sales (K Pcs) by Type (2018-2024)
Table 23. Latin America T Cell Surface Glycoprotein CD4 Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales (K Pcs) by Type (2018-2024)
Table 25. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales by Type (2018-2024) & (US$ Million)
Table 26. Global T Cell Surface Glycoprotein CD4 Sales by Company (2018-2024) & (K Pcs)
Table 27. Global T Cell Surface Glycoprotein CD4 Sales Share by Company (2018-2024)
Table 28. Global T Cell Surface Glycoprotein CD4 Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global T Cell Surface Glycoprotein CD4 Revenue Share by Company (2018-2024)
Table 30. Global Market T Cell Surface Glycoprotein CD4 Price by Company (2018-2024) & (USD/Pcs)
Table 31. Global T Cell Surface Glycoprotein CD4 Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global T Cell Surface Glycoprotein CD4 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in T Cell Surface Glycoprotein CD4 as of 2022)
Table 34. Date of Key Manufacturers Enter into T Cell Surface Glycoprotein CD4 Market
Table 35. Key Manufacturers T Cell Surface Glycoprotein CD4 Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global T Cell Surface Glycoprotein CD4 Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global T Cell Surface Glycoprotein CD4 Sales by Region (2018-2024) & (K Pcs)
Table 39. Global T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Region (2018-2024)
Table 40. Global T Cell Surface Glycoprotein CD4 Sales by Region (2018-2024) & (US$ Million)
Table 41. Global T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Region (2018-2024)
Table 42. Global T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 43. Global T Cell Surface Glycoprotein CD4 Sales by Region (2024-2034) & (K Pcs)
Table 44. Global T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Region (2024-2034)
Table 45. Global T Cell Surface Glycoprotein CD4 Sales by Region (2024-2034) & (US$ Million)
Table 46. Global T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Region (2024-2034)
Table 47. Global T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 48. Global T Cell Surface Glycoprotein CD4 Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global T Cell Surface Glycoprotein CD4 Sales by Application (2018-2024) & (K Pcs)
Table 50. Global T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Application (2018-2024)
Table 51. Global T Cell Surface Glycoprotein CD4 Sales by Application (2018-2024) & (US$ Million)
Table 52. Global T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Application (2018-2024)
Table 53. Global T Cell Surface Glycoprotein CD4 Price by Application (2018-2024) & (USD/Pcs)
Table 54. Global T Cell Surface Glycoprotein CD4 Sales by Application (2024-2034) & (K Pcs)
Table 55. Global T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Application (2024-2034)
Table 56. Global T Cell Surface Glycoprotein CD4 Sales by Application (2024-2034) & (US$ Million)
Table 57. Global T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Application (2024-2034)
Table 58. Global T Cell Surface Glycoprotein CD4 Price by Application (2024-2034) & (USD/Pcs)
Table 59. North America T Cell Surface Glycoprotein CD4 Sales by Application (2018-2024) (K Pcs)
Table 60. North America T Cell Surface Glycoprotein CD4 Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe T Cell Surface Glycoprotein CD4 Sales by Application (2018-2024) (K Pcs)
Table 62. Europe T Cell Surface Glycoprotein CD4 Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales by Application (2018-2024) (K Pcs)
Table 64. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America T Cell Surface Glycoprotein CD4 Sales by Application (2018-2024) (K Pcs)
Table 66. Latin America T Cell Surface Glycoprotein CD4 Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales by Application (2018-2024) (K Pcs)
Table 68. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales by Application (2018-2024) & (US$ Million)
Table 69. North America T Cell Surface Glycoprotein CD4 Sales by Country (2018-2024) & (K Pcs)
Table 70. North America T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Country (2018-2024)
Table 71. North America T Cell Surface Glycoprotein CD4 Sales by Country (2018-2024) & (US$ Million)
Table 72. North America T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Country (2018-2024)
Table 73. North America T Cell Surface Glycoprotein CD4 Sales by Country (2024-2034) & (K Pcs)
Table 74. North America T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Country (2024-2034)
Table 75. North America T Cell Surface Glycoprotein CD4 Sales by Country (2024-2034) & (US$ Million)
Table 76. North America T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Country (2024-2034)
Table 77. Europe T Cell Surface Glycoprotein CD4 Sales by Country (2018-2024) & (K Pcs)
Table 78. Europe T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe T Cell Surface Glycoprotein CD4 Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Country (2018-2024)
Table 81. Europe T Cell Surface Glycoprotein CD4 Sales by Country (2024-2034) & (K Pcs)
Table 82. Europe T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe T Cell Surface Glycoprotein CD4 Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales by Region (2018-2024) & (K Pcs)
Table 86. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales by Region (2024-2034) & (K Pcs)
Table 90. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America T Cell Surface Glycoprotein CD4 Sales by Country (2018-2024) & (K Pcs)
Table 94. Latin America T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America T Cell Surface Glycoprotein CD4 Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America T Cell Surface Glycoprotein CD4 Sales by Country (2024-2034) & (K Pcs)
Table 98. Latin America T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America T Cell Surface Glycoprotein CD4 Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales by Country (2018-2024) & (K Pcs)
Table 102. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales by Country (2024-2034) & (K Pcs)
Table 106. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Country (2024-2034)
Table 109. Biotest AG Company Information
Table 110. Biotest AG Introduction and Business Overview
Table 111. Biotest AG T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 112. Biotest AG T Cell Surface Glycoprotein CD4 Product
Table 113. Biotest AG Recent Development
Table 114. Bristol-Myers Squibb Co Company Information
Table 115. Bristol-Myers Squibb Co Introduction and Business Overview
Table 116. Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 117. Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Product
Table 118. Bristol-Myers Squibb Co Recent Development
Table 119. CEL-SCI Corp Company Information
Table 120. CEL-SCI Corp Introduction and Business Overview
Table 121. CEL-SCI Corp T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 122. CEL-SCI Corp T Cell Surface Glycoprotein CD4 Product
Table 123. CEL-SCI Corp Recent Development
Table 124. Fountain Biopharma Inc Company Information
Table 125. Fountain Biopharma Inc Introduction and Business Overview
Table 126. Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 127. Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Product
Table 128. Fountain Biopharma Inc Recent Development
Table 129. Immupharma Plc Company Information
Table 130. Immupharma Plc Introduction and Business Overview
Table 131. Immupharma Plc T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 132. Immupharma Plc T Cell Surface Glycoprotein CD4 Product
Table 133. Immupharma Plc Recent Development
Table 134. Sanofi Company Information
Table 135. Sanofi Introduction and Business Overview
Table 136. Sanofi T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 137. Sanofi T Cell Surface Glycoprotein CD4 Product
Table 138. Sanofi Recent Development
Table 139. TaiMed Biologics Inc Company Information
Table 140. TaiMed Biologics Inc Introduction and Business Overview
Table 141. TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 142. TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Product
Table 143. TaiMed Biologics Inc Recent Development
Table 144. United Biomedical Inc Company Information
Table 145. United Biomedical Inc Introduction and Business Overview
Table 146. United Biomedical Inc T Cell Surface Glycoprotein CD4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 147. United Biomedical Inc T Cell Surface Glycoprotein CD4 Product
Table 148. United Biomedical Inc Recent Development
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. T Cell Surface Glycoprotein CD4 Market Trends
Table 152. T Cell Surface Glycoprotein CD4 Market Drivers
Table 153. T Cell Surface Glycoprotein CD4 Market Challenges
Table 154. T Cell Surface Glycoprotein CD4 Market Restraints
Table 155. T Cell Surface Glycoprotein CD4 Distributors List
Table 156. T Cell Surface Glycoprotein CD4 Downstream Customers
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. T Cell Surface Glycoprotein CD4 Product Picture
Figure 2. Global T Cell Surface Glycoprotein CD4 Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global T Cell Surface Glycoprotein CD4 Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global T Cell Surface Glycoprotein CD4 Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Forigerimod Acetate
Figure 6. Global Forigerimod Acetate Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of HIV Vaccine 2
Figure 8. Global HIV Vaccine 2 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Ibalizumab
Figure 10. Global Ibalizumab Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Global T Cell Surface Glycoprotein CD4 Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Type in 2022 & 2034
Figure 15. North America T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Type in 2022
Figure 16. North America T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Type in 2022
Figure 17. Europe T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Type in 2022
Figure 18. Europe T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Type in 2022
Figure 21. Latin America T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Type in 2022
Figure 22. Latin America T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by T Cell Surface Glycoprotein CD4 Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by T Cell Surface Glycoprotein CD4 Revenue in 2022
Figure 27. T Cell Surface Glycoprotein CD4 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of HIV
Figure 29. Global HIV Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Product Picture of AIDS
Figure 31. Global AIDS Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of GVHD
Figure 33. Global GVHD Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of SARS
Figure 35. Global SARS Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Global T Cell Surface Glycoprotein CD4 Sales by Application (2018-2034) & (US$ Million)
Figure 39. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Application in 2022 & 2034
Figure 40. North America T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Application in 2022
Figure 41. North America T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Application in 2022
Figure 42. Europe T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Application in 2022
Figure 43. Europe T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Application in 2022
Figure 46. Latin America T Cell Surface Glycoprotein CD4 Sales Market Share in Volume by Application in 2022
Figure 47. Latin America T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. T Cell Surface Glycoprotein CD4 Manufacturing Cost Structure
Figure 51. T Cell Surface Glycoprotein CD4 Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries